Eye scans may foretell diabetes vision loss and heart trouble

NCT ID NCT07417410

Recruiting now Knowledge-focused Sponsor: Association for Innovation and Biomedical Research on Light and Image Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This observational study will follow 1,000 people with type 2 diabetes for one year to see if changes in the eye's blood vessels and tissues can predict worsening diabetic retinopathy and related heart problems. Researchers will use advanced imaging and medical records to track eye health and major cardiovascular events like heart attack or stroke. The goal is to better identify who is at risk, so doctors can intervene earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which patients with diabetes are at highest risk for vision loss or heart problems, allowing earlier and more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It may find patterns that are not strong enough to reliably predict outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic retinopathy type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC RETINOPATHY

Contacts and locations

Locations

AIBILI-Clinical Trial Centre
RECRUITING

Portugal, Coimbra District, 3000-548, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.